- •Bone loss accelerates sharply in the trans-menopause window: SWAN found ~10.5% spine BMD loss over roughly 5 years around the final period.
- •Estrogen is the master regulator of bone turnover — losing it lets bone breakdown outpace bone building.
- •The WHI found estrogen therapy reduced hip fractures by ~33% — the strongest fracture prevention data of any menopause intervention.
- •Resistance training and impact loading are the only exercise types that reliably build bone; walking alone is not enough.
- •Rapid weight loss — including on a GLP-1 — can accelerate bone loss, making this doubly important if you're doing both at once.
Why does menopause cause bone loss?
Because estrogen is the brake on bone breakdown, and menopause takes the brake off.
Your skeleton is not inert. It's a living tissue in constant turnover, managed by two cell types:
- •Osteoclasts break down old bone.
- •Osteoblasts build new bone.
In a healthy premenopausal woman, these are roughly balanced. Estrogen restrains osteoclast activity and supports osteoblast survival. Take estrogen away, and osteoclasts get louder while osteoblasts can't keep up. Bone breakdown outpaces bone formation, and net bone mass falls.
The timing is what makes this urgent. The SWAN study — the largest longitudinal study of the menopause transition — found that bone loss doesn't happen gradually across your 50s and 60s. It clusters violently around the final menstrual period. SWAN researchers found the fastest loss occurred in the year before and the two years after the final period, with cumulative losses of roughly 10.5% at the spine and 5.8% at the hip across the transition.
That's a tenth of your spinal bone density in about five years.
And here's the part that gets missed: you cannot feel it. Osteoporosis is completely silent until something breaks. There is no symptom, no warning ache, no early sign. The first indication for many women is a wrist fracture from a minor fall, or a vertebral compression fracture found incidentally on an X-ray taken for something else.
Which means prevention isn't something you start when you notice a problem. By definition, you won't.
How do you know if your bones are at risk?
You test. There's no other way — the disease is silent by design.
The DEXA scan. A dual-energy X-ray absorptiometry scan measures bone mineral density at the hip and spine. It's quick, painless, low-radiation, and it gives you a T-score:
- •T-score above -1.0 → normal bone density.
- •T-score between -1.0 and -2.5 → osteopenia (low bone mass, elevated risk).
- •T-score at or below -2.5 → osteoporosis.
When to get one. Standard guidance recommends DEXA screening for all women at age 65, and earlier for women with risk factors. In practice, if you're going through menopause and have any of the risk factors below, it's worth asking for a baseline scan now — because a single scan tells you where you are, but two scans over time tell you how fast you're losing, which is far more useful.
Risk factors that should move you up the queue:
- •Early menopause (before 45) or surgical menopause — fewer years of estrogen exposure.
- •Family history of osteoporosis or hip fracture, particularly in a parent.
- •Low body weight or a BMI under about 19.
- •Smoking and heavy alcohol use — both directly toxic to bone.
- •Long-term corticosteroid use (e.g. prednisone for asthma or autoimmune disease).
- •A history of an eating disorder or long-term under-eating.
- •Rapid or significant weight loss — including on a GLP-1 medication.
- •Certain conditions: hyperthyroidism, hyperparathyroidism, celiac disease, rheumatoid arthritis.
FRAX. The FRAX tool estimates your 10-year fracture probability from your risk factors, with or without a DEXA result. It's free, it's what your doctor uses, and it's worth knowing your number.
Does HRT prevent osteoporosis?
Yes — and this is one of the most solidly established benefits of hormone therapy, backed by fracture data rather than just density data.
The Women's Health Initiative (WHI), despite its complicated legacy, produced unambiguous bone findings. In the estrogen-plus-progestin arm, hormone therapy reduced hip fractures by about 33% and reduced clinical vertebral fractures by a similar margin, compared with placebo. That is a *fracture* endpoint — the outcome that actually matters — not a surrogate marker.
Estrogen is currently the only menopause therapy that both prevents bone loss and has demonstrated fracture reduction in a large randomized trial in women without established osteoporosis.
But there are important nuances:
- •The protection lasts as long as you take it. Bone loss resumes when estrogen therapy stops, and density gained tends to be lost over subsequent years. HRT is not a course you complete.
- •Timing matters. The [timing hypothesis](/blog/when-to-start-hrt-the-timing-hypothesis-explained) holds that starting HRT within about 10 years of menopause (or before age 60) offers a better benefit-risk profile than starting later. The bone benefit is present in both windows; the cardiovascular and overall risk picture is not.
- •HRT is not prescribed for bone alone in most guidelines. It's typically considered when a woman also has vasomotor symptoms, or when other bone treatments aren't suitable. That said, bone protection is a legitimate part of the conversation and should be weighed in the decision.
- •The 30-year WHI follow-up (Manson et al., JAMA 2024) reaffirmed a generally favorable benefit-risk balance for symptomatic women starting therapy in their 50s — meaningfully softening the fear that dominated the 2000s.
The honest bottom line: if you're a candidate for HRT and you're at bone risk, this deserves a real conversation with a menopause-informed clinician — not a reflexive no.
What exercise actually builds bone?
Bone responds to load and impact. It does not respond meaningfully to gentle, low-stress movement — and this is where most well-intentioned advice fails women.
What works:
1. Resistance training with meaningful load. Bone adapts when muscle pulls hard on it. That requires weight that is genuinely challenging — think a load you could lift 6-10 times before form breaks down, not a pink dumbbell for 30 reps. Prioritize compound movements that load the hip and spine directly: squats, deadlifts, hip thrusts, overhead press, rows, loaded carries. Two to three sessions a week. Our full [resistance training guide for menopause](/blog/resistance-training-for-menopause-bone-density-strength-guide) has the programming.
2. Impact loading. Bone responds to ground reaction forces. Jumping, hopping, skipping, bounding — even 10-20 hops a day has evidence behind it for hip BMD. Start where you are: if jumping isn't accessible, heel drops (rise onto toes, drop onto heels) provide a scaled version of the same stimulus.
3. Progressive overload. This is the whole mechanism. Bone adapts to *increasing* demand. If the weight never goes up, the stimulus stops being a stimulus. Doing the same workout for two years builds nothing.
What doesn't build bone (though it's still good for you):
- •Walking. Excellent for cardiovascular health, mood, and weight management — but the load is too low to drive meaningful bone adaptation. [Walking is worth doing](/blog/walking-for-menopause-benefits-and-how-much); just don't count it as your bone plan.
- •Swimming and cycling. Non-weight-bearing. Great for fitness, near-zero bone stimulus.
- •Yoga and Pilates. Genuinely valuable for balance, mobility, and fall prevention — which prevents fractures! — but not a bone-building stimulus on their own.
Balance training deserves its own mention. Most fractures happen because someone falls. Reducing fall risk is a direct fracture-prevention strategy, and single-leg balance work costs you nothing.
What should you eat to protect your bones?
Three nutrients do most of the heavy lifting, and one of them is routinely forgotten.
Calcium: 1,000-1,200mg per day. Postmenopausal women generally need around 1,200mg daily. Food first — dairy, fortified plant milks, canned sardines and salmon with bones, tofu set with calcium, leafy greens, almonds. Split your intake: the gut absorbs calcium best in doses of 500mg or less, so 600mg twice a day beats 1,200mg at once. And don't over-supplement: very high calcium supplement intake has been associated with cardiovascular concerns in some studies, and more is not better.
Vitamin D: 800-2,000 IU per day for most women. Without adequate vitamin D you simply cannot absorb the calcium you're eating. Deficiency is extremely common, particularly at northern latitudes and in women with darker skin. Get your level tested rather than guessing — most clinicians target a serum 25(OH)D above 30 ng/mL. Our [calcium and vitamin D guide](/blog/calcium-and-vitamin-d-in-menopause-bone-protection-plan) has the details.
Protein: the forgotten bone nutrient. Roughly half of bone volume is protein matrix — collagen — with mineral deposited onto it. Chronic under-eating of protein means you can't build the scaffold, no matter how much calcium you take. Aim for 1.2-1.6g per kg of body weight daily, spread across meals. This matters enormously for women who are also losing weight.
Also worth knowing:
- •Vitamin K2 supports the proteins that direct calcium into bone. Found in fermented foods, natto, and some cheeses. Evidence is promising rather than definitive.
- •Magnesium is a cofactor in vitamin D metabolism. [Magnesium for menopause](/blog/magnesium-for-menopause-which-type-and-how-much) covers dosing.
- •Alcohol directly impairs osteoblast function. More than about one drink a day is a genuine bone risk, not a moralistic caution.
- •Smoking is one of the strongest modifiable risk factors for fracture.
- •Under-eating in general — chronic energy deficiency suppresses the hormones that maintain bone, full stop.
Does GLP-1 weight loss increase osteoporosis risk?
It can — and if you're doing GLP-1 weight loss *during* menopause, you are stacking two independent bone risks on top of each other. This deserves direct attention, not reassurance.
Why weight loss costs bone. Bone responds to mechanical load, and body weight *is* mechanical load. When you carry less weight, your skeleton receives a smaller signal to maintain density. On top of that, rapid weight loss of any kind — surgical, dietary, or pharmacological — is consistently associated with reductions in bone mineral density. Losing 15-20% of body weight is a large mechanical unloading event.
Why menopause compounds it. You're already in the fastest bone-loss window of your life. Adding an unloading stimulus to an estrogen-deficient skeleton is a genuine double hit — we cover the mechanism in depth in [GLP-1 + menopause: the bone density double risk](/blog/glp1-menopause-bone-density-double-risk-protect-your-bones).
This is not an argument against GLP-1 medications. The metabolic and cardiovascular benefits are real and substantial — SELECT (NEJM 2023) found a 20% reduction in major cardiovascular events with semaglutide. Obesity itself carries serious risks. The point is that bone needs to be actively defended while you lose weight, not assumed to be fine.
The protection protocol if you're doing both:
1. Get a baseline DEXA before or early in treatment. You cannot detect loss you never measured. 2. Hit your protein target every day — 1.2-1.6g/kg, non-negotiable. Reduced appetite makes this genuinely hard; plan for it. 3. Resistance train 2-3x weekly with progressive load. This is the single most important countermeasure. 4. Don't lose faster than you have to. Aggressive rapid loss costs more lean mass and bone than steady loss. 5. Discuss HRT with your doctor if you're a candidate — it directly addresses the estrogen side of the equation. 6. Rescan in 12-24 months to see what actually happened rather than what you hoped happened.
Done deliberately, you can get the metabolic benefits and keep your skeleton. Done passively, you may not.
Frequently asked questions
- Bone mineral density loss in relation to the final menstrual period in a multiethnic cohort (SWAN) (2012)
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women (WHI) (2002)
- Menopausal Hormone Therapy and Long-term Health Outcomes: WHI 30-Year Follow-up (2024)
- Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes (SELECT) (2023)
Lea is an AI health companion trained on landmark clinical studies covering GLP-1 medications and menopause. Our content is evidence-based and regularly updated to reflect the latest research.
This article is for informational purposes only and is not medical advice. Always consult your healthcare provider.
Learn more about LeaHave questions about this?
Ask Lea — she'll apply this directly to your medication, your symptoms, your week.
Talk to Lea